Information Provided By:
Fly News Breaks for August 6, 2018
PCRX
Aug 6, 2018 | 07:30 EDT
Wedbush analyst Liana Moussatos raised her price target for Pacira to $85 from $80 after the company delivered better than expected Q2 earnings and revenue and raised EXPAREL net product sales full-year guidance from $300M-$310M to $320M-$325M. The analyst reiterates an Outperform rating on the shares.
News For PCRX From the Last 2 Days
There are no results for your query PCRX